Over the last 10 years, prescribing GLP-1RAs has become increasingly prevalent due to their significant impact on diabetes disease control, weight loss, and cardiovascular disease risk reduction
Technique matters more than most articles acknowledge
Serious hypersensitivity, acute kidney injury from dehydration, and diabetic retinopathy considerations are also documented in the label
Variants in GIPR (rs1800437 in particular, associated with differential GLP-1 response), FTO (appetite regulation), MC4R (satiety signaling), and TCF7L2 (insulin response) are linked to measurably different response patterns to semaglutide
This allows us to provide cost-effective alternatives to brand-name medications while maintaining the same efficacy